亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

格列美脲生產(chǎn)廠家-價(jià)格,最大原料生產(chǎn)廠家強(qiáng)勢(shì)供應(yīng)

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
品牌 東康源
過期 長(zhǎng)期有效
更新 2014-04-28 10:40
 

武漢東康源精細(xì)化學(xué)品有限公司

企業(yè)會(huì)員第12年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明
     格列美脲廠家對(duì)格列美脲行情、價(jià)格、參數(shù)進(jìn)行的詳細(xì)介紹。
 
一.下面由東康源為您對(duì)格列美脲做一番簡(jiǎn)單的介紹:
1.cas 登入號(hào):93479-97-1
2.產(chǎn)品分子式:C24H34N4O5S
3.產(chǎn)品分子量:490.6156
4.外觀和性狀:白色結(jié)晶粉末
5.作用及用途:用作降血糖藥
 
二.如果還想詳細(xì)了解格列美脲的話,不妨看看下面的參數(shù):
1.中文名稱:格列美脲
2.中文別名:格列美吡拉;格列吡咯;賀普丁
3.化學(xué)名稱:1-[4-[2-(3-乙基-4-甲基-2-氧代-3-吡咯啉-1-甲酰胺基)-乙基]-苯磺酰]-3-(反式-4-甲基環(huán)己基)-脲;反式-3-乙基-2,5-二氫-4-甲基-N-[2-[4-[[[[(4-甲基環(huán)己基)氨基]羰基]氨基]磺酰基]苯基]乙基]-2-氧-1H-吡咯-1-羧酰胺
4.英文名稱:Glimepiride
 
    假如您還心存疑惑的話,歡迎致電格列美脲生產(chǎn)廠家東康源咨詢格列美脲價(jià)格、格列美脲廠家、格列美脲供應(yīng)商以及其他方面的信息。 
    格列美脲的應(yīng)用,格列美脲在有機(jī)實(shí)驗(yàn)中的應(yīng)用,格列美脲在無機(jī)實(shí)驗(yàn)中的應(yīng)用,格列美脲在細(xì)胞實(shí)驗(yàn)方面的應(yīng)用,格列美脲在大鼠等動(dòng)物實(shí)驗(yàn)方面的應(yīng)用;格列美脲的溶解性,格列美脲在PBS緩沖液中的溶解性,格列美脲在DMSO、乙醇等有機(jī)溶劑中的溶解性。 
     
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |